9946 related articles for article (PubMed ID: 1686168)
1. Proto-oncogene expression in dermal naevi and melanomas.
Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
Arch Dermatol Res; 1991; 283(8):500-5. PubMed ID: 1686168
[TBL] [Abstract][Full Text] [Related]
2. Expression of proto-oncogenes in normal and tumor tissues of human skin.
Ogiso Y; Oikawa T; Kondo N; Kuzumaki N; Sugihara T; Ohura T
J Invest Dermatol; 1988 Jun; 90(6):841-4. PubMed ID: 2897396
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
Carr J; Mackie RM
Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
[TBL] [Abstract][Full Text] [Related]
6. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
7. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
8. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
Schmid P; Itin P; Rufli T
Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
[TBL] [Abstract][Full Text] [Related]
9. High BRAF mutation frequency does not characterize all melanocytic tumor types.
Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
Orian JM; Vasilopoulos K; Yoshida S; Kaye AH; Chow CW; Gonzales MF
Br J Cancer; 1992 Jul; 66(1):106-12. PubMed ID: 1322154
[TBL] [Abstract][Full Text] [Related]
11. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
[TBL] [Abstract][Full Text] [Related]
12. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.
Platz A; Ringborg U; Grafström E; Höög A; Lagerlöf B
Melanoma Res; 1995 Apr; 5(2):101-6. PubMed ID: 7620336
[TBL] [Abstract][Full Text] [Related]
14. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in skin tumors induced in hairless mice by chronic exposure to ultraviolet B irradiation.
Sato H; Suzuki JS; Tanaka M; Ogiso M; Tohyama C; Kobayashi S
Photochem Photobiol; 1997 May; 65(5):908-14. PubMed ID: 9155265
[TBL] [Abstract][Full Text] [Related]
17. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
20. Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas.
Basarab T; Picard JK; Simpson E; Russell-Jones R
Br J Dermatol; 1999 Jan; 140(1):106-8. PubMed ID: 10215777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]